- Define the critical quality attributes of the formulations produced using the Nanospresso machine and cartridge.
- Develop and implement a comprehensive quality control strategy for both bulk-phase and single-particle analysis, ensuring alignment with the formulation goals.
- Investigate and apply novel approaches for single-particle analysis, integrating findings into an iterative optimization loop to refine the Nanospresso formulation concept.
Leader of WP2
Dr. Sven Even Borgos
Senior Research Scientist – SINTEF, Dept. of Biotechnology and Nanomedicine
Short bio: Borgos has an undergraduate in biophysics, a PhD in molecular genetics, and is working for almost 20 years in SINTEF, on analytical chemistry. The main focus of his research for the last decade has been physicochemical characterization and, more recently, formulation of nanomedicines. He is leading the SINTEF work in numerous European and national projects on nucleic acid medicines.
Other Involved Partners
Results
We are collecting results that will be posted here soon. Stay tuned.
